Federal award
ROCHE DIAGNOSTICS CORPORATION
FA860120F0065
Contract
Obligated and Ceiling
- Obligated (net)
- $276,029.76
- Ceiling (potential value, not spending)
- $276,029.76
- Current value
- $276,029.76
- Gross positive obligations
- $276,029.76
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ROCHE DIAGNOSTICS CORPORATION · JDMDFEZBYH36
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- FOUNDATION MEDICINE, INC. · EHXPZ92G4AD1
- Awarding agency
- Department of War · sub-agency 5700 · office FA8601
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- FA860120F0065
- Parent vehicle (IDV PIID)
- FA860117A0005
- Award type code
- A
- Actions
- 2 · Jan 17, 2020 to Jan 31, 2020
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History2
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 31, 2020 | FY2020 | P00001 | M | $0.00 | — |
| Jan 17, 2020 | FY2020 | 0 | — | $276,029.76 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.